Stay updated with breaking news from Eric Miska. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new Fellows have been elected to the Academy in recognition of their exceptional contributions to the advancement of biomedical and health science,
/PRNewswire/ -- STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms, today...
STORM to deliver small molecule ADAR1 clinical candidate compounds discovered using its proprietary RNA modifying enzyme drug discovery platform ALAMEDA, Calif. and CAMBRIDGE, England,
STORM to deliver small molecule ADAR1 clinical candidate compounds discovered using its proprietary RNA modifying enzyme drug discovery platform - Exelixis, Inc. (Nasdaq: EXEL) and STORM Therapeutics